Join KBI Biopharma, Inc. at CAR-TCR: Engineering A Disease-Free World! Be sure to stop by Booth #A101 and chat with KBI's Senior Director of Business Development, Brian Newsom. And don't miss Brian's Tech Talk: How to effectively work with a CDMO to advance your cell therapy program. We look forward to seeing you there!
How to effectively work with a CDMO to advance your cell therapy program
Tech Talk presented by Brian Newsom
This presentation will cover the necessities in working with a Contract Development and Manufacturing Organization (CDMO) to advance your cell therapy program, including:
KBI Biopharma is a leading global contract development and manufacturing organization (CDMO) providing fully integrated, accelerated drug development and biologics manufacturing services and expertise to life science companies. With each of our 500+ client partners, we work closely to personalize and accelerate drug development programs. Built upon a foundation of world-class analytics capabilities and extensive scientific and technical expertise, we deliver robust process development and clinical and commercial cGMP manufacturing services for mammalian, microbial, and cell therapy programs. Recognized for quality manufacturing, we help clients advance drug candidates into the clinic and beyond.
The hotly anticipated 7th Annual CAR-TCR Summit is back, bigger and better than ever, uniting experts with one common goal: engineering a disease-free world. After the explosive news that CAR-T therapies can now be considered curative, now is the time to unite with your industry, from the long-standing commercial giants to the trailblazing pioneers, and discover new strategies for everything from discovery to early phase development to commercialization. Gain end-to-end insights from both established thought leaders and the innovators bringing disruptive technologies from bench to bedside and from vein to vein. Across 3 conference days with 8 tracks, 13 Workshops, 1 Bootcamp and 1 Focus Day, 200+ CAR and TCR experts will lead you and 1,000 of your peers in discussions that will accelerate your pipeline and bring much-needed treatments to patients faster.
Visit the conference website >>